Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from GeoVax Labs ( (GOVX) ).
On January 9, 2026, GeoVax Labs, Inc. implemented a 1-for-25 reverse stock split of its common stock, combining every 25 previously issued and outstanding shares into one new share with the same par value. No fractional shares were issued, with any resulting fractional positions rounded up to the next whole share, leaving shareholders’ overall percentage ownership and voting power essentially unchanged and the rights and privileges of common stockholders substantially unaffected.
The most recent analyst rating on (GOVX) stock is a Hold with a $0.16 price target. To see the full list of analyst forecasts on GeoVax Labs stock, see the GOVX Stock Forecast page.
Spark’s Take on GOVX Stock
According to Spark, TipRanks’ AI Analyst, GOVX is a Neutral.
The score is primarily held down by weak financial performance (declining revenue, large losses, and significant cash burn) and bearish technicals (price below key moving averages with negative momentum). Potential upside from the earnings call (expedited regulatory path and partnership interest) provides some offset, but valuation remains constrained by ongoing losses and no dividend support.
To see Spark’s full report on GOVX stock, click here.
More about GeoVax Labs
Average Trading Volume: 1,905,878
Technical Sentiment Signal: Sell
Current Market Cap: $8M
For a thorough assessment of GOVX stock, go to TipRanks’ Stock Analysis page.